CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for RLS Global AB is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

RLS Global AB
Neongatan 5 1Tr
Phone: +46 31531806p:+46 31531806 MOELNDAL, 431 53  Sweden Fax: +46 317806821f:+46 317806821
Filed for Bankruptcy on 11/20/2023
On 11/20/2023, the Board of Directors of RLS Global AB announced its decision to file for Bankruptcy proceedings with the Gothenburg District Court.
The Company was declared Bankrupt by the Gothenburg District Court.
This company is no longer actively traded on any major stock exchange.
Business Summary
RLS Global AB, formerly OraSolv Products AB, is a Sweden-based company engaged in the development of dental care products. It is primarily engaged in the development of biochemical products and methods for minimally invasive dentistry. The Company’s product portfolio includes Carisolv, a biochemical method for the removal of caries; Perisolv, product for the treatment of periodontitis; ChloraSolv, a treatment that cleanses and heals chronic wounds and Kindersolv, a caries treatment for children. The Company manufactures its products in the Sahlgrenska Science Park and sells them through distributors worldwide. The Company’s main shareholders are Rls Global Intressenter AB, Joki Invest AB, Zebra Holdings and Investments Limited.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202312/31/2022Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Steven E.Krognes 54 1/1/2021 1/1/2016
Chief Executive Officer, Director RolandFrosing 7/10/2023 1/1/2021
Chief Financial Officer TorbjornSannerstedt 62 8/22/2023 8/22/2023
7 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 79,874,705 (As of 6/30/2023)
Stock Exchange: STO
Fax Number: +46 317806821


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024